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Dermatologists marvel over lesions that move within hours to
days; they have embellished those lesions with descriptive names
and have searched for their etiologies and pathophysiologies for
over a century. Some of the rapidly moving lesions are caused
by parasites migrating through the skin (Ancyclostoma brasilense
causing cutaneous larva migrans or Strongyloides stercolis infesta-
tion); some are reactions to a de¢ned organism, such as strepto-
cocci in erythema marginatum of rheumatic fever, or erythema
migrans associated with Borrelia burgdorferi infection. Migrating
skin lesions may be seen in some cases of erythrokeratoderma
variabilis. Other common migrating skin lesions, often classi¢ed
under the rubric of ¢gurate erythemas, include erythema annu-
lare centri¢gum (EAC). EAC describes lesions that usually have
an arcuate or polycyclic urticarial border and move with a narrow
band of scale just behind its leading edge; as the lesion appears to
migrate, it leaves behind brownish hyperpigmentation. EAC may
persist from weeks to years. Its pathophysiology is uncertain,
although it is associated infrequently with internal malignancy,
infections or drug hypersensitivity. New ¢ndings in the cuta-
neous biology of inherited diseases may have uncovered a clue
to studying and understanding EAC.
In this issue (p. 482), Gu and coworkers describe patients with
Epidermolysis Bullosa Simplex (EBS) due to a newly discovered
mutation in Keratin 5 (K5), with many typical features of the
EBS phenotype. The patients, from two families, one Korean
and the other Japanese, had an autosomal dominant disease with
migratory blistering lesions that resolved with brownish pigmen-
tation. Both patients have the same K5 mutation, with a predicted
35 amino acid extension.This clinical picture is remarkable and is
not part of the phenotype of any forms of EBS. The authors call
this condition EB with ‘‘migratory circinate erythema’’. Detailed
dermal histopathology was not described. In skin sections, the
abnormal epidermis did not react or reacted only slightly to
anti-K5 antibodies, suggesting that the abnormal molecule was
altering normal K5 epitopes even on the unaltered K5 molecule
in the epidermis.
There are reports of K1, K10 and K2e mutations with similar
migratory lesions (called by several of the authors ‘‘annular epi-
dermolytic hyperkeratosis’’) with characteristics of EAC. The re-
ports are summarized brie£y inTable I below. In one personally
studied family with a Keratin 2e mutation, all of the family
members with Ichthyosis Bullosa of Siemens (IBS) also had le-
sions of EAC (Case 1, Suga et al, 2000). The EAC-like lesions
were not described in the original report of this family. One
member has an antinuclear antibody titer of 1:320, and this family
is currently under study (Scott and Goldsmith, unpublished).The
mutation caused changes in residue 493 in the 2B helix, a hot spot
in EAC. Other patients with IBS mutations of amino acid 493
have not been described as having EAC; however, this may be a
di⁄cult diagnosis to make in the presence of IBS. In the cases of
presumptive EAC associated with keratin mutations there are
point mutations or (in one case) a double mutation, usually in a
highly conserved helical portion of a keratin molecule. Similar
cases of EAC with an epidermolytic hyperkeratosis-like disorder
and EAC features have been reported, but have not been studied
molecularly (Sahn et al, 1992). Molecular keratin diagnosis and
connexin studies would be useful in this and similar families to
establish or eliminate the possibility of keratin and connexin de-
fects in these patients. Patients with mutations identical to those
in Annular Epidermolytic Hyperkeratosis are reported without
EAC-like lesions. It may be useful to examine those patients for
EAC.
The hypothesis usually advanced to explain these EAC-like le-
sions is molecular: due to the protein alteration, there are changes
in keratin or keratin-associated structures that cause the lesions
through unspeci¢ed mechanisms. Another set of hypotheses
would include the possibility that the migratory lesions have
an immunological basis and that altering concentrations of
Table I. Erythema Annulare Centri¢gum-like lesions associated with Keratin defects
Disease Designation Molecule and mutation Residue and Protein Alterations Reference
Cyclic ichthyosis with Epidermolytic
Hyperkeratosis
K1 1436T4C (case1)
K1 1435 A4T (case2)
I479T in 2B helical
I479F in 2B helical
Sybert et al, 1999
Epidermolytic hyperkeratosis with polycyclic
psoriasiform plaques
K1 1435A4T I479F in 2B helical Michael et al, 1999
Ichthyosis Bullosa of Siemens K2e 1510G4A (case1)
K2e 1512G4T (case2)
E493K in 2B segment
E493D in 2B segment
Suga et al, 2000
Epidermolyis bullosa simplex with migratory
circinate erythema
K5 1449 delG K5 35 amino acid longer Gu et al, 2003
Annular Epidermolytic Ichthyosis K10 1264-1265CG4GA R422E in 2B helix Joh et al, 1997
Annular Epidermolytic Hyperkeratosis K10 1337T4C I446T in 2B helix Suga et al, 1998
Annular Epidermolytic Ichthyosis K10 473G4C A158P 1A helix Yoneda et al, 1999
Original molecular data in some cases modi¢ed in Mutation database for intermediate ¢laments (www.inter¢l.org).
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proin£ammatory and anti-in£ammatory cytokines are responsi-
ble for the rapid movement of the lesions. In outline, that hy-
pothesis considers that keratins are usually immunologically
privileged molecules and that an individual does not have signif-
icant autoimmune reactions to these molecules because of the
induction of tolerance. In the elongated K5 molecule ^ or mole-
cules with altered macromolecular con¢gurations in the certain
K1, K2e, and K10 mutations described ^ these molecules might
become antigenic. The antigenic portions of the molecules may
be intrinsic portions of the molecule such as the 35 amino acid
K5 tail in the patients reported. Or, they may be post-transla-
tional-formed portions of epidermal proteins, including the ci-
trullinated residues derived from arginine or transglutaminase
modi¢ed molecules (Utz et al, 2000). In addition, molecules not
normally synthesized during tolerance induction might be pre-
sent in the diseased epidermis, and these might be the antigens
for autoantibodies.
We propose that careful clinical, histological and immunologi-
cal studies in all patients with disorders of keratin with associated
migratory skin lesions be performed to develop data to test the
immunological and other hypotheses. Such studies eventually
may shed light on the mechanism of the more common forms
of EAC.
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